C-Type Natriuretic Peptide Attenuates Evoked Dopamine Efflux by Influencing Go alpha

Hypertension

Volumn 33, Issue 1, 1999, Pages 124-129

  Takida, Satoshi ^a   Elmquist, Barbara J ^a   Trachte, George J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; N(G) METHYLARGININE; NATRIURETIC PEPTIDE TYPE C;

ADRENERGIC TRANSMISSION; ANIMAL CELL; ARTICLE; DEPOLARIZATION; DOPAMINE UPTAKE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

ANALYSIS OF VARIANCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CATECHOLAMINES; CYCLIC GMP; DATA INTERPRETATION, STATISTICAL; DOPAMINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; ENZYME INHIBITORS; GTP-BINDING PROTEINS; GUANYLATE CYCLASE; HUMANS; MOLECULAR SEQUENCE DATA; NATRIURETIC PEPTIDE, C-TYPE; NG-NITROARGININE METHYL ESTER; OLIGONUCLEOTIDES, ANTISENSE; PC12 CELLS; RATS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TUBULIN;

EID: 0032917236     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.33.1.124     Document Type: Article

References (33)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981;28:89-94.
2. Flynn TG, de Bold ML, de Bold AJ. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Comm. 1983;117:859-865.
3. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78-81.
4. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Comm. 1990;168:863-870.
5. Chinkers M, Garbers SL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature. 1989;338:78-83.
6. Schulz S, Green CK, Yuen PST, Garbers DL. Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell. 1990;63:941-948.
7. Lewicki JA, Protter AA. Molecular determinants of natriuretic peptide clearance receptor function. In: Samson WK, Levin ER, eds. Contemporary Endocrinology: Natriuretic Peptides in Health and Disease. Totawa, NJ: Humana Press; 1997:51-69.
8. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987;238:675-678.
9. Brandt RR, Heublein DM, Aarhus LL, Lewicki JA, Burnett JC Jr. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Am J Physiol. 1995;269:H326-H331.
10. Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol. 1993;264:E483-E489.
11. Smyth EM, Keenan AK. The vascular ANF-C receptor: role in atrial peptide signaling. Cell Signal. 1994;6:125-133.
12. Trachte GJ. Physiology of the clearance receptor. In: Samson WK, Levin ER, eds. Contemporary Endocrinology: Natriuretic Peptides in Health and Disease. Totawa, NJ: Humana Press; 1997:259-274.
13. Anand-Srivastava MB, Sehl PD, Lowe DG. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase involvement of a pertussis toxin-sensitive G protein. J Biol Chem. 1996;271:19324-19329.
14. Drewett JG, Ziegler RJ, Trachte GJ. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase. J Pharmacol Exp Ther. 1992;257:689-696.
15. Trachte GJ, Kanwal S, Elmquist BJ, Ziegler RJ. C-type natriuretic peptide neuromodulates via "clearance" receptors. Am J Physiol. 1995;268:C978-C984.
16. Elferink JG, De Koster BM. Atrial natriuretic factor stimulates migration by human neutrophils. Eur J Pharmacol. 1995;288:335-340.
17. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 1991;353:43-48.
18. Kalkbrenner F, Dippel E, Wittig B, Schultz G. Specificity of interaction between receptor and G protein: use of antisense techniques to relate G protein subunits to function. Biochim Biophys Acta. 1996;1314:125-139.
19. Babinski K, Haddad P, Vallerand D, McNicoll N, De Lean A, Ong H. Natriuretic peptides inhibit nicotine-induced whole-cell currents and catecholamine secretion in bovine chromaffin cells: evidence for the involvement of the atrial natriuretic factor R2 receptors. J Neurochem. 1995;64:1080-1087.
20. Drewett JG, Ziegler RJ, Trachte GJ. Neuromodulatory effects of ANF are independent of guanylate cyclase in adrenergic, neuronal pheochromocytoma cells. J Pharmacol Exp Ther. 1990;255:497-503.
21. Anand-Srivastava MB, Sairam MR, Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. J Biol Chem. 1990;265:8566-8572.
22. Prins BA, Weber MJ, Hu RM, Pedram A, Daniels M, Levin ER. Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation. J Biol Chem. 1996;271:14156-14162.
23. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
24. Rathinavelu A, Isom GE. Differential internalization and processing of atrial natriuretic factor B and C receptors in PC12 cells. Biochem J. 1991;276:493-497.
25. Hirsch DB, Steiner JP, Dawson TM, Mammed A, Hayek E, Snyder SH. Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Curr Biol. 1993;3:749-754.
26. Kanwal S, Elmquist BJ, Trachte GJ. Atrial natriuretic peptide inhibits evoked catecholamine release by altering sensitivity to calcium. J Pharmacol Exp Ther. 1997;283:426-433.
27. Douglas WW. Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Br J Pharmacol. 1968;34:451-474.
28. Lotshaw DP, Franco-Saenz R, Mulrow PJ. Atrial natriuretic peptide inhibition of calcium ionophore A23187-stimulated aldosterone secretion in rat adrenal glomerulosa cells. Endocrinology. 1991;129:2305-2310.
29. 2+ conductance and reduces cAMP via a cGMP-independent mechanism. Am J Physiol. 1992;263:C334-C342.
30. Bittner MA, Holz RW, Neubig RR. Guanine nucleotide effects on catecholamine secretion from digitonin-permeabilized adrenal chromaffin cells. J Biol Chem. 1986;261:10182-10188.
31. Ohara-Imaizumi M, Kameyama K, Kawae N, Takeda K, Muramatsu S, Kumakura K. Regulatory role of the GTP-binding protein, Go, in the mechanism of exocytosis in adrenal chromaffin cells. J Neurchem. 1992;58:2275-2284.
32. Vitale N, Gonon F, Thierse D, Aunis D, Bader MF. Exocytosis in single chromaffin cells: regulation by a secretory granule-associated Go protein. Cell Mol Neurobiol. 1997;17:71-87.
33. Khurana ML, Pandey KN. Modulation of guanylate cyclase-coupled atrial natriuretic factor receptor activity by mastoparan and ANF in murine Leydig tumor cells: role of G-proteins. Biochim Biophys Acta. 1994;1224:61-67.